VytronUS, a medical device startup that remains secretive about its product, has raised another $11 million in its first round of funding, according to VentureWire. That new money, from existing investors Delphi Ventures and New Enterprise Associates, brings the total amount raised to $17 million.

The Sunnyvale, Calif., company says it’s developing a cardiovascular device that’s entering animal trials, but isn’t offering more details.


VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
  • up-to-date information on the subjects of interest to you
  • our newsletters
  • gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
  • networking features, and more
Become a member